Patient Rating:

4.9 out of 5

34 Patient Ratings
23 Patient Comments

David K. Gaffney, M.D., Ph.D.

Vice-Chair, Department of Radiation Oncology

Clinical Details

Schedule An Appointment Clinical Office Address
(801) 581-2396 Huntsman Cancer Hospital
1950 Circle of Hope
Salt Lake City, UT 84112
Map

Bio

David Gaffney, MD, PhD, is vice-chair, medical director, and professor of radiation oncology at the University of Utah School of Medicine and Huntsman Cancer Institute. His primary clinical interests are in the radiotherapeutic management of gynecological cancers, breast cancers, and lymphoma. His main research interests are in clinical trial development, prognostic markers, and secondary cancers.

Gaffney is interested in clinical trials that improve survival and quality of life for cancer patients. He serves as a co-Chair for the National Cancer Institute Gynecologic Cancer Steering Committee. He previously was chair of the Gynecologic Working Group for the Radiation Therapy Oncology Group (RTOG). The RTOG is a multi-institutional cooperative cancer research organization that conducts clinical trials. He is active in the Gynecologic Cancer Intergroup (a worldwide organization of clinical trial groups). Gaffney chairs the American College of Radiology Radiation Oncology Appropriateness Criteria Gynecologic panel. He also is an editor for the ACR Journal Advisor for gyncologic radiation oncology. Gaffney is the chair of the Clinical Cancer Investigation Committee at the University of Utah and Huntsman Cancer Institute. He serves as a Senior Editor for the International Journal of Gynecologic Cancer, Gynecologic Oncology, and the American Journal of Clinical Oncology.

In addition, Gaffney is interested in radiation sensitizers, which are drugs that make cancer cells more sensitive to the effects of radiation therapy. Dr. Gaffney enjoys working with medical students and residents on a wide variety of projects.

Gaffney received his PhD in biochemistry from the Medical College of Wisconsin in 1990 and his MD from the same institution in 1992. He completed an internship at LDS Hospital in Salt Lake City, Utah, and a residency in radiation oncology at the University of Utah School of Medicine.

Board Certification and Academic Information

Academic Departments Radiation Oncology - Professor
Board Certification American Board of Radiology (Radiation Oncology)
Cancer Center Programs Experimental Therapeutics

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Likelihood of recommending care provider
5.0
My confidence in care provider
5.0
Time care provider spent with me
4.9
Care provider spoke using clear language
5.0
Care provider's effort to include me in decisions
4.8
Care provider's concern for questions & worries
4.8
Care provider's explanation of condition/problem
4.9
Wait time at clinic
4.9
Care provider's friendliness and courtesy
5.0

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

June 14, 2014

Dr. Gaffney and Dr. Williams always seem genuinely interested and concerned, as well as very competent, and they make me feel like they have plenty of time to spend with me. I appreciate this very much.

May 31, 2014

I needed an ultrasound of my breast in addition to my mammogram and I didn't have to wait long. The radiology fellow was very good, professional and kind. The radiologist was also very good, but waited until 10 minutes into our conversation to report to me that my mammogram looked clear and that they were looking for a benign papilloma in my milk ducts; that information would have been a great way to start our conversation.

May 15, 2014

I have already recommended Dr. Gaffney to others.

March 28, 2014

posed for photos with patient even!

February 14, 2014

The best

January 31, 2014

Good

January 25, 2014

This was an annual checkup. No insight given for continuing pain at incision sites.

January 18, 2014

definitely recommend this place

January 16, 2014

I have always found Dr. Gaffney to be a very caring person about me personally. He puts me at ease and makes me feel like I am a person to him and not just a name on a chart.

September 30, 2013

I love everyone who has ever seen me in my 3 1/2 years of going to the Huntsmans.

September 26, 2013

I have felt very good about my experiences at the Huntsman and that I have received the best care and concern.

September 20, 2013

Every person who has seen me at Huntsman Cancer Institute has been professional, forthcoming with information, kind as an angel and concerned about me individually. I've never experienced such loving care for anything in my life. If I could, I'd live in a back room at Huntsman and come out every morning to soak up the healing, positive energy I feel within the building itself and from the wonderful people and facilities. I have to go back to Arizona where I live but I am looking forward to my three month visits at Huntsman with Dr. Gaffney, Dr. Soisson and RN Colleen, and the rest of the dear staff. If I could only sit in the lobby and hear the pianist I feel I'd be well and wise in no time. Please thank him for his generosity of time and talent. I listen to him for as long as he plays everytime.

April 29, 2013

In that my appt was changed at my request and squeezed into the morning schedule, I was amazed at the unhurried time I felt I had with the nurse, resident and doctor. Thank you.

April 29, 2013

care provider staff was very professional.

April 25, 2013

Dr. Gaffney is extremely easy to talk with and his positive attitude makes the entire process easy and comfortable.

April 08, 2013

I liked the fact that Dr. Gaffney came in personally, and did the followup check. He was personable and informative, as he always is.

March 26, 2013

Dr. Gaffney has always been very informative and clear on every step. I have full faith and confidence in his ability.

March 05, 2013

Everyone was very nice and compassionate with my situation.

March 04, 2013

I already have recommended Dr. Gaffney to another friend who has just been dx'd with breast cancer.

January 21, 2013

Everyone was spookier friendly!

January 21, 2013

Dr. Gaffney was awesome...my husband and I are not neophytes in regards to health care and my diagnosis. He treated us with respect and intelligence.

December 06, 2012

Dr. Gaffney is a good listener and very nice! Very smart also. Dr. Wagner is also very good.

September 10, 2012

Dr. Gaffney maintained eye contact for several seconds after the exam and before he left. I felt like a human being to him

Academic Profile

Board Certification and Academic Information

Academic Departments Radiation Oncology - Professor
Board Certification American Board of Radiology (Radiation Oncology)
Cancer Center Programs Experimental Therapeutics

Academic Office Locations

Academic Office Phone Number Academic Office Address
(801) 581-2396 Huntsman Cancer Hospital
Radiation Oncology
1950 Circle of Hope
Salt Lake City, UT 84112

Academic Bio

David Gaffney, MD, PhD, is vice-chair and professor of radiation oncology at the University of Utah School of Medicine and Huntsman Cancer Institute. He is an HCI investigator and member of the Experimental Therapeutics program. His primary clinical interests are in the radiotherapeutic management of gynecological cancers, breast cancers, and lymphoma. His main research interests are in clinical trial development, prognostic markers, and secondary cancers.

Gaffney is interested in clinical trials that improve survival and quality of life for cancer patients. He serves as chair of the Gynecologic Working Group for the Radiation Therapy Oncology Group (RTOG). The RTOG is a multi-institutional cooperative cancer research organization that conducts clinical trials. He is active in the Gynecologic Cancer Intergroup (a worldwide organization of clinical trial groups). He serves on a National Cancer Institute panel evaluating gynecologic clinical trials. Gaffney is the chair of the Clinical Cancer Investigation Committee at the University of Utah and Huntsman Cancer Institute. He serves as a Senior Editor for the International Journal of Gynecologic Cancer, and he is a member of multiple professional societies.

In addition, Gaffney is interested in radiation sensitizers, which are drugs that make cancer cells more sensitive to the effects of radiation therapy. Dr. Gaffney enjoys working with medical students and residents on a wide variety of projects.

Gaffney received his PhD in biochemistry from the Medical College of Wisconsin in 1990 and his MD from the same institution in 1992. He completed an internship at LDS Hospital in Salt Lake City, Utah, and a residency in radiation oncology at the University of Utah School of Medicine.

Education

Education History

Type School Degree
Residency University of Utah
Radiation Oncology
Resident
Internship LDS Hospital
Intern
Professional Medical Medical College of Wisconsin
Medicine
M.D.
Doctoral Training Medical College of Wisconsin
Biochemistry
Ph.D.
Undergraduate University of Colorado
Chemistry
B.A.

Publications

Selected Provider Publications

Journal Article

  1. COX-2 Expression and Survival in Patients With Locally Advanced Cervical Cancer Treated With Chemoradiotherapy and Celecoxib: A Quantitative Immunohistochemical Analysis of RTOG C0128.Doll CM, Winter K, Gaffney DK, Ryu JK, Jhingran A, Dicker AP, Weidhaas JB, Miller BE, Magliocco AM (2013). COX-2 Expression and Survival in Patients With Locally Advanced Cervical Cancer Treated With Chemoradiotherapy and Celecoxib: A Quantitative Immunohistochemical Analysis of RTOG C0128. Int J Gynecol Cancer, 23(1), 176-183.
  2. The Role of Palliative External Beam Radiation Therapy in Boney Metastases Pain Management.Cai B, Nickman NA, Gaffney DK (2013). The Role of Palliative External Beam Radiation Therapy in Boney Metastases Pain Management. J Pain Palliat Care Pharmacother.
  3. Impact of tumor size on survival in cancer of the cervix and validation of stage IIA1 and IIA2 subdivisions.Wagner AE, Pappas L, Ghia AJ, Gaffney DK (2013). Impact of tumor size on survival in cancer of the cervix and validation of stage IIA1 and IIA2 subdivisions. Gynecol Oncol, 129(3), 517-21.
  4. Ribonucleotide reductase expression in cervical cancer: a radiation therapy oncology group translational science analysis.Kunos CA, Winter K, Dicker AP, Small W Jr, Abdul-Karim FW, Dawson D, Jhingran A, Valicenti R, Weidhaas JB, Gaffney DK (2013). Ribonucleotide reductase expression in cervical cancer: a radiation therapy oncology group translational science analysis. Int J Gynecol Cancer, 23(4), 615-21.
  5. Survival analysis of endometrial cancer patients with positive lymph nodes.Brown AP, Gaffney DK, Dodson MK, Soisson AP, Belnap TW, Alleman K, Sause WT (2013). Survival analysis of endometrial cancer patients with positive lymph nodes. Int J Gynecol Cancer, 23(5), 861-8.
  6. Mycosis Fungoides: The Addition of Concurrent and Adjuvant Interferon to Total Skin Electron Beam Therapy.LID - 10.1111/bjd.12386 [doi]Wagner AE, Wada D, Bowen G, Gaffney DK (2013). Mycosis Fungoides: The Addition of Concurrent and Adjuvant Interferon to Total Skin Electron Beam Therapy.LID - 10.1111/bjd.12386 [doi]. Br J Dermatol.
  7. Survival Analysis of Cancer Patients With FIGO Stage IIIA Endometrial Cancer.Lum MM, Belnap TW, Frandsen J, Brown AP, Sause WT, Soisson AP, Dodson MK, Werner T, Gaffney DK (2013). Survival Analysis of Cancer Patients With FIGO Stage IIIA Endometrial Cancer. Am J Clin Oncol.
  8. Page, BR, Belnap, TR, Bowen, RC, Gaffney, DK, Sause, WT (November 2013). Utilization of Hypofractionated and Conventional Breast Radiotherapy in the State of Utah. Cancer and Clinical Oncology, 2(2), 34-41.
  9. ACR Appropriateness Criteria(R) role of adjuvant therapy in the management of early stage cervical cancer.Wolfson AH, Varia MA, Moore D, Rao GG, Gaffney DK, Erickson-Wittmann BA, Jhingran A, Mayr NA, Puthawala AA, Small W Jr, Yashar CM, Yuh W, Cardenes HR (2012). ACR Appropriateness Criteria(R) role of adjuvant therapy in the management of early stage cervical cancer. Gynecol Oncol, 125(1), 256-62.
  10. The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128.Viswanathan AN, Moughan J, Small W Jr, Levenback C, Iyer R, Hymes S, Dicker AP, Miller B, Erickson B, Gaffney DK (2012). The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128. Int J Gynecol Cancer, 22(1), 123-31.
  11. Is short-interval mammography necessary after breast conservation surgery and radiation treatment in breast cancer patients?Hymas RV, Gaffney DK, Parkinson BT, Belnap TW, Sause WT (2012). Is short-interval mammography necessary after breast conservation surgery and radiation treatment in breast cancer patients? Int J Radiat Oncol Biol Phys, 83(2), 519-24.
  12. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy.Viswanathan AN, Beriwal S, De Los Santos JF, Demanes DJ, Gaffney D, Hansen J, Jones E, Kirisits C, Thomadsen B, Erickson B (2012). American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy. Brachytherapy, 11(1), 47-52.
  13. American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy.Small W Jr, Beriwal S, Demanes DJ, Dusenbery KE, Eifel P, Erickson B, Jones E, Rownd JJ, De Los Santos JF, Viswanathan AN, Gaffney D (2012). American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy. Brachytherapy, 11(1), 58-67.
  14. A Phase II Study of Bevacizumab in Combination With Definitive Radiotherapy and Cisplatin Chemotherapy in Untreated Patients With Locally Advanced Cervical Carcinoma: Preliminary Results of RTOG 0417.Schefter TE, Winter K, Kwon JS, Stuhr K, Balaraj K, Yaremko BP, Small W Jr, Gaffney DK (2012). A Phase II Study of Bevacizumab in Combination With Definitive Radiotherapy and Cisplatin Chemotherapy in Untreated Patients With Locally Advanced Cervical Carcinoma: Preliminary Results of RTOG 0417. Int J Radiat Oncol Biol Phys, 83(4), 1179-84.
  15. Does the FIGO 2009 endometrial cancer staging system more accurately correlate with clinical outcome in different histologies? Revised staging, endometrial cancer, histology.Page BR, Pappas L, Cooke EW, Gaffney DK (2012). Does the FIGO 2009 endometrial cancer staging system more accurately correlate with clinical outcome in different histologies? Revised staging, endometrial cancer, histology. Int J Gynecol Cancer, 22(4), 593-8.
  16. Advances in clinical research in gynecologic radiation oncology: an RTOG symposium.Gaffney D, Mundt A, Schwarz J, Eifel P (2012). Advances in clinical research in gynecologic radiation oncology: an RTOG symposium. Int J Gynecol Cancer, 22(4), 667-74.
  17. Determination of cytokine protein levels in oral secretions in patients undergoing radiotherapy for head and neck malignancies.Citrin DE, Hitchcock YJ, Chung EJ, Frandsen J, Urick ME, Shield W 3rd, Gaffney D (2012). Determination of cytokine protein levels in oral secretions in patients undergoing radiotherapy for head and neck malignancies. Radiat Oncol, 7(1), 64.
  18. A phase II study of intensity modulated radiation therapy to the pelvis for postoperative patients with endometrial carcinoma: radiation therapy oncology group trial 0418.Jhingran A, Winter K, Portelance L, Miller B, Salehpour M, Gaur R, Souhami L, Small W Jr, Berk L, Gaffney D (2012). A phase II study of intensity modulated radiation therapy to the pelvis for postoperative patients with endometrial carcinoma: radiation therapy oncology group trial 0418. Int J Radiat Oncol Biol Phys, 84(1), e23-8.
  19. ACR Appropriateness Criteria((R)) Pretreatment Planning of Invasive Cancer of the Cervix.Siegel CL, Andreotti RF, Cardenes HR, Brown DL, Gaffney DK, Horowitz NS, Javitt MC, Lee SI, Mitchell DG, Moore DH, Rao GG, Royal HD, Small W Jr, Varia MA, Yashar CM (2012). ACR Appropriateness Criteria((R)) Pretreatment Planning of Invasive Cancer of the Cervix. J Am Coll Radiol, 9(6), 395-402.
  20. ACR Appropriateness Criteria(R) definitive therapy for early-stage cervical cancer.Small W Jr, Strauss JB, Jhingran A, Yashar CM, Cardenes HR, Erickson-Wittmann BA, Gullett N, Kidd E, Lee LJ, Mayr NA, Moore D, Puthawala AA, Rao GG, Varia MA, Wahl AO, Wolfson AH, Yuh W, Gaffney DK (2012). ACR Appropriateness Criteria(R) definitive therapy for early-stage cervical cancer. Am J Clin Oncol, 35(4), 399-405.
  21. Survey on the Management of Early Cervical Cancer Among Members of the GCIG.Lindsay R, Paul J, Siddiqui N, Davis J, Gaffney DK (2012). Survey on the Management of Early Cervical Cancer Among Members of the GCIG. Int J Gynecol Cancer.
  22. Characterization of clinical course and usual care patterns in female metastatic breast cancer patients treated with zoledronic acid.LID - S0960-9776(12)00198-1 [pii]LID - 10.1016/j.breast.2012.09.012 [doi]Young J, Nickman NA, Biskupiak JE, Barney RB, Gaffney DK, Namjoshi M, Brandt P (2012). Characterization of clinical course and usual care patterns in female metastatic breast cancer patients treated with zoledronic acid.LID - S0960-9776(12)00198-1 [pii]LID - 10.1016/j.breast.2012.09.012 [doi]. Breast.
  23. Optimal therapy for IB2 and IIA2 cervical cancer: surgery or chemoradiotherapy?Gaffney DK (2012). Optimal therapy for IB2 and IIA2 cervical cancer: surgery or chemoradiotherapy? J Gynecol Oncol, 23(4), 207-9.
  24. Impact of Comorbid Conditions on Survival in Endometrial Cancer.Nicholas Z, Hu N, Ying J, Soisson P, Dodson M, Gaffney DK (2012). Impact of Comorbid Conditions on Survival in Endometrial Cancer. Am J Clin Oncol.
  25. Viswanathan AN, Thomadsen B (01/08/2013). American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles. Brachytherapy, 11(1), 33-46.
  26. ACR Appropriateness Criteria(R) on Advanced Cervical Cancer Expert Panel on Radiation Oncology-Gynecology.Gaffney DK, Erickson-Wittmann BA, Jhingran A, Mayr NA, Puthawala AA, Moore D, Rao GG, Small W Jr, Varia MA, Wolfson AH, Yashar CM, Yuh W, Cardenes HR (2011). ACR Appropriateness Criteria(R) on Advanced Cervical Cancer Expert Panel on Radiation Oncology-Gynecology. Int J Radiat Oncol Biol Phys, 81(3), 609-14.
  27. Primary vaginal cancer and chemoradiotherapy: a patterns-of-care analysis.Ghia AJ, Gonzalez VJ, Tward JD, Stroup AM, Pappas L, Gaffney DK (2011). Primary vaginal cancer and chemoradiotherapy: a patterns-of-care analysis. Int J Gynecol Cancer, 21(2), 378-84.
  28. ACR Appropriateness Criteria(R) Pretreatment Evaluation and Follow-Up of Endometrial Cancer of the Uterus.Lee JH, Dubinsky T, Andreotti RF, Cardenes HR, Dejesus Allison SO, Gaffney DK, Glanc P, Horowitz NS, Jhingran A, Lee SI, Puthawala AA, Royal HD, Scoutt LM, Small W Jr, Varia MA, Zelop CM (2011). ACR Appropriateness Criteria(R) Pretreatment Evaluation and Follow-Up of Endometrial Cancer of the Uterus. Ultrasound Q, 27(2), 139-45.
  29. Cooke EW, Pappas L, Gaffney DK (09/15/11). Does the Revised International Federation of Gynecology and Obstetrics Staging System for Endometrial Cancer Lead to Increased Discrimination in Patient Outcomes? Cancer, 117(18), 4231-4239.
  30. Gaffney DK, Werner TL (In Press). Curative Treatment for Recurrent and Metastatic Cervix Cancer? Expert Rev Anticancer Ther.

Book

  1. David K Gaffney, Dennis C Shrieve, Christopher J Anker, Mark K Buyyounouski, Feng-Ming Kong, Ying J Hitchcock, Jonathan D Tward (12/2012). Radiation Oncology: Imaging and Treatment. Amirsys.

Book Chapter

  1. Jonathan D Tward, Christopher J Anker, David K Gaffney and Glen M Bowen (March 2012). Radiation Therapy and Skin Cancer. In Modern Practices in Radiation Therapy.
  2. Mayer NA, Gaffney DK, Small Q (May 2011). Cervical Cancer (Ch. 22). In Liu JL, Brady LW (Ed.), Decision Making in Radiation Oncology (pp. 662-701). Springer.
  3. Anker CA, Gaffney DK (2011). Ovary. In Shrieve DC, Loeffler J (Ed.), Human Radiation Injury (1st, pp. 365-384). Philadelphia: Lippencott Williams and Wilkins.
  4. Ghia A, Gaffney DK (2011). Radiotherapy for Vaginal and Vulvar Cancers. In Ali Ayhan, Nicholas Reed, Murat Gultekin, Polat Dursun (Ed.), Textbook of Gynaecological Oncology (First). Istanbul: Gunes Publishing.
  5. Gonzalez VJ, Gaffney DK (2011). Vagina. In Shrieve DC, Loeffler J (Ed.), Human Radiation Injury (1st, pp. 385-402). Philadelphia: Lippencott WIlliams and Wilkins.

Clinical Trials

Video & News